"モデルナ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonModerna to Test New COVID-19 Vaccine Against Placebo as CDC Official Resigns Amid Leadership Chan...
Moderna to Test New COVID-19 Vaccine Against Placebo as CDC Official Resigns Amid Leadership Changes geneonline.com
Moderna (MRNA) Advances While Market Declines: Some Information for Investors - MSN
Moderna (MRNA) Advances While Market Declines: Some Information for Investors MSN
More Adults Can Now Get Moderna's RSV Shot - WebMD
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults - Reuters
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults Reuters
Moderna, Inc. - Britannica
Moderna, Inc. Britannica
‘People inside Moderna are afraid’: As anti-vaccine climate intensifies, the company has much to ...
HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines - CIDRAP
HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines CIDRAP
Moderna’s SWOT analysis: mRNA pioneer’s stock faces pivotal moment - Investing.com
Moderna’s SWOT analysis: mRNA pioneer’s stock faces pivotal moment Investing.com
How Moderna Went From Pandemic Hero to Vaccine Victim - WSJ
Moderna (NASDAQ:MRNA) Trading Down 3.8% - Time to Sell? - MarketBeat
Moderna (NASDAQ:MRNA) Trading Down 3.8% - Time to Sell? MarketBeat
FDA expands approval of Moderna's RSV vaccine to some adults under age 60 - ABC News - Breaking N...
FDA expands approval of Moderna's RSV vaccine to some adults under age 60 ABC News - Breaking News, Latest News and Videos
FDA clears Moderna’s new COVID vaccine, but with limits - BioPharma Dive
FDA clears Moderna’s new COVID vaccine, but with limits BioPharma Dive
HHS axes Moderna's $590M pandemic bird flu vaccine contract, ending funding for late-phase trials...
HHS axes Moderna's $590M pandemic bird flu vaccine contract, ending funding for late-phase trials Fierce Biotech
Trump's HHS cancels Moderna's $590M bird flu vaccine award - Axios
Trump's HHS cancels Moderna's $590M bird flu vaccine award Axios
FDA Approves Moderna’s COVID-19 Vaccine - ContagionLive
FDA Approves Moderna’s COVID-19 Vaccine ContagionLive
MAHA v. Moderna: The COVID vaccine maker is under attack by RFK Jr.'s department of health - Fast...
MAHA v. Moderna: The COVID vaccine maker is under attack by RFK Jr.'s department of health Fast Company
Moderna receives expanded approval for RSV vaccine - CIDRAP
BDF Gestion Invests $783,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
BDF Gestion Invests $783,000 in Moderna, Inc. (NASDAQ:MRNA) MarketBeat
Moderna’s vaccine hit, the MAHA report, and an ASCO preview - STAT
Moderna’s vaccine hit, the MAHA report, and an ASCO preview STAT
HHS terminates Moderna contract to develop bird flu vaccine - BioPharma Dive
HHS terminates Moderna contract to develop bird flu vaccine BioPharma Dive
Trump administration cancels $766 million Moderna contract to fight pandemic flu - AP News
Trump administration cancels $766 million Moderna contract to fight pandemic flu AP News
US cancels more than $700 million funding for Moderna bird flu vaccine - Reuters
US cancels more than $700 million funding for Moderna bird flu vaccine Reuters
Moderna falls on doubts over new CDC panel's backing of RSV vaccine - Reuters
Moderna falls on doubts over new CDC panel's backing of RSV vaccine Reuters
Moderna wins FDA OK to widen use of RSV vaccine - BioPharma Dive
Moderna wins FDA OK to widen use of RSV vaccine BioPharma Dive
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine - The New York Times
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine The New York Times
Here's Why Moderna (MRNA) Fell More Than Broader Market - Yahoo Finance
Here's Why Moderna (MRNA) Fell More Than Broader Market Yahoo Finance
Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine - Investopedia
Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine Investopedia
HHS Misleads on mRNA Vaccine Safety After Pulling Moderna Funding - FactCheck.org
HHS Misleads on mRNA Vaccine Safety After Pulling Moderna Funding FactCheck.org
Moderna Wins Expanded Label for mRNA RSV Shot as New ACIP Members Question mRNA Technology - BioS...
Moderna Wins Expanded Label for mRNA RSV Shot as New ACIP Members Question mRNA Technology BioSpace
A road map for startups, from Moderna’s co-founder - MIT Sloan
A road map for startups, from Moderna’s co-founder MIT Sloan
SG Americas Securities LLC Lowers Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
SG Americas Securities LLC Lowers Stake in Moderna, Inc. (NASDAQ:MRNA) MarketBeat
HHS cancels $766M in funding for Moderna to develop MRNA vaccine against bird flu - NBC News
HHS cancels $766M in funding for Moderna to develop MRNA vaccine against bird flu NBC News
Moderna Wins FDA Approval for Next-Gen COVID-19 Vaccine Despite ‘Investor Nervousness’ - BioSpace
Moderna Wins FDA Approval for Next-Gen COVID-19 Vaccine Despite ‘Investor Nervousness’ BioSpace
FDA Approves Moderna’s mNEXSPIKE COVID-19 Vaccine After Phase III Trial Showing Comparable Effica...
FDA Approves Moderna’s mNEXSPIKE COVID-19 Vaccine After Phase III Trial Showing Comparable Efficacy to Spikevax geneonline.com
Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount - BioSpace
Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount BioSpace
Moderna’s RSV vaccine mRESVIA granted FDA approval to protect younger adults - PMLiVE
Moderna’s RSV vaccine mRESVIA granted FDA approval to protect younger adults PMLiVE
FDA approves a next-generation Covid vaccine from Moderna, with restrictions - STAT
FDA approves a next-generation Covid vaccine from Moderna, with restrictions STAT
Moderna Target of Unusually High Options Trading (NASDAQ:MRNA) - MarketBeat
Moderna Target of Unusually High Options Trading (NASDAQ:MRNA) MarketBeat
Moderna (MRNA) Sees Bullish Trading Activity with Increased Options Volume | MRNA Stock News - Gu...
Moderna (MRNA) Sees Bullish Trading Activity with Increased Options Volume | MRNA Stock News GuruFocus
HHS cancels $590 million contract with Moderna for bird flu vaccine - CNN
HHS cancels $590 million contract with Moderna for bird flu vaccine CNN
FDA approves Moderna's new COVID-19 vaccine - CIDRAP
Is Moderna Stock A Buy After Winning A Surprise Approval? - Investor's Business Daily
Is Moderna Stock A Buy After Winning A Surprise Approval? Investor's Business Daily
FDA approves new Moderna COVID-19 vaccine - Axios
Moderna suffers a $750 million loss from NIH funding cut - Yahoo Finance
Moderna suffers a $750 million loss from NIH funding cut Yahoo Finance
HHS cancels funding for Moderna vaccines to fight pandemic flu - The Hill
HHS cancels funding for Moderna vaccines to fight pandemic flu The Hill
FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains - The Hill
FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains The Hill
Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19 -...
Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19 Nature
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA - Fortune
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA Fortune
Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike - Yahoo Finance
Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike Yahoo Finance
Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors. - Barron's
Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors. Barron's
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Tobam - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Tobam MarketBeat
Moderna says FDA has been constructive, but delays flu/COVID shot - Reuters
Moderna says FDA has been constructive, but delays flu/COVID shot Reuters
Is it Time to Dump Your Shares of Moderna? - The Motley Fool
Is it Time to Dump Your Shares of Moderna? The Motley Fool
Why Moderna Merged Its Tech and HR Departments - WSJ
Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash. - Barron's
Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash. Barron's
Moderna pulls licensing submission for combo flu-COVID vaccine - CIDRAP
Moderna pulls licensing submission for combo flu-COVID vaccine CIDRAP
HHS cancels $766 million in Moderna contracts for vaccines for flu pandemics - STAT
HHS cancels $766 million in Moderna contracts for vaccines for flu pandemics STAT
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it -...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it CBS News
Moderna (MRNA) Sees Bearish Sentiment Among Option Traders | MRNA Stock News - GuruFocus
Moderna (MRNA) Sees Bearish Sentiment Among Option Traders | MRNA Stock News GuruFocus
FDA approves Moderna’s new COVID-19 vaccine - Santa Clarita Valley Signal
FDA approves Moderna’s new COVID-19 vaccine Santa Clarita Valley Signal
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts - BioSpace
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts BioSpace
Moderna files for review of updated COVID vaccine - Reuters
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older - Reuters
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older Reuters
Can Moderna Stock Keep Its Rally Going? - Nasdaq
Why Moderna Stock Is Crumbling - Nasdaq
Moderna targets more cost cuts amid broader vaccine market uncertainty under HHS secretary RFK Jr...
Moderna targets more cost cuts amid broader vaccine market uncertainty under HHS secretary RFK Jr. Fierce Pharma
FDA Expands Label for Moderna's mRNA RSV Vaccine to Include At-Risk Adults Aged 18 to 59 Years - ...
FDA Expands Label for Moderna's mRNA RSV Vaccine to Include At-Risk Adults Aged 18 to 59 Years Patient Care Online
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59 - STAT
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59 STAT
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut - Yahoo Fin...
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut Yahoo Finance
Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More - Investopedia
Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More Investopedia
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults - Pharmaceutical Technology
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults Pharmaceutical Technology
Moderna pulls application for COVID-flu combination shot - Reuters
Moderna pulls application for COVID-flu combination shot Reuters
Moderna pulls application for combo COVID, flu shot - BioPharma Dive
Moderna pulls application for combo COVID, flu shot BioPharma Dive
Trump administration cancels plans to develop a bird flu vaccine - NPR
Trump administration cancels plans to develop a bird flu vaccine NPR
Arbutus and Brinkhof celebrate interim success in mRNA case against Moderna - JUVE Patent
Arbutus and Brinkhof celebrate interim success in mRNA case against Moderna JUVE Patent
Why Vaccine-Maker Moderna Is Injecting AI Across the Company - Inc.com
Why Vaccine-Maker Moderna Is Injecting AI Across the Company Inc.com
Trump administration yanks Moderna's bird flu vaccine research funding even as company reports pr...
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled - BioSpace
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled BioSpace
Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy ...
Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data Fierce Biotech
Why Moderna, Inc. (MRNA) Skyrocketed Today - Yahoo Finance
Why Moderna, Inc. (MRNA) Skyrocketed Today Yahoo Finance
HHS cancels funding for Moderna to develop vaccines to combat bird flu - The Washington Post
HHS cancels funding for Moderna to develop vaccines to combat bird flu The Washington Post
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review - Yahoo Finance
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review Yahoo Finance
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars...
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? Crowell & Moring LLP
Why Moderna, Inc. (MRNA) Surged Today - Yahoo Finance
Why Moderna, Inc. (MRNA) Surged Today Yahoo Finance
Moderna's combo Covid and flu mRNA shot outperforms current vaccines in large trial - NBC News
Moderna's combo Covid and flu mRNA shot outperforms current vaccines in large trial NBC News
Moderna opens UK vaccine manufacturing lab in Harwell - BBC
As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious - Barron's
As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious Barron's
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long” - Yahoo Finance
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long” Yahoo Finance
Study estimates current Moderna vaccine 53% effective against COVID hospitalization - CIDRAP
Study estimates current Moderna vaccine 53% effective against COVID hospitalization CIDRAP
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot - AP News
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot AP News
Moderna surprises the Street by predicting a bigger-than-expected sales drop - AP News
Moderna surprises the Street by predicting a bigger-than-expected sales drop AP News
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Ri...
Moderna 'voluntarily' pulls FDA application for combo flu/COVID-19 vaccine - FirstWord Pharma
Moderna 'voluntarily' pulls FDA application for combo flu/COVID-19 vaccine FirstWord Pharma
Moderna COVID Vaccine Technology Struck Down by PTAB - IPWatchdog.com
Moderna COVID Vaccine Technology Struck Down by PTAB IPWatchdog.com
Moderna faces PMCPA audit over ‘completely unacceptable’ lack of transparency - Fierce Pharma
Moderna faces PMCPA audit over ‘completely unacceptable’ lack of transparency Fierce Pharma
Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant...
Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant Fierce Pharma
Moderna’s mRESVIA Vaccine Faces Market Challenges Despite FDA Approval - TipRanks
Moderna’s mRESVIA Vaccine Faces Market Challenges Despite FDA Approval TipRanks
Moderna: Fair Value Lowered on ‘Hostile’ FDA Environment - Morningstar
Moderna: Fair Value Lowered on ‘Hostile’ FDA Environment Morningstar
Moderna makes more spending cuts, updates vaccine plans - STAT
Moderna makes more spending cuts, updates vaccine plans STAT
Behind Moderna’s Quiet Gamble on China - WSJ